24.95USD-4.52%Mkt Cap: 1.73B $P/E: —1d ago
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a prote…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap1.73B $
Enterprise Value2.09B $
Revenue (TTM)87.16M $
Gross Profit41.70M $
Net Income (TTM)-29.82M $
Revenue/Share7.387 USD
Last Price24.95 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees222
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-35.45
PEG—
EV/EBITDA-65.05
EV/Revenue23.95
P/S19.84
P/B-9.71
EPS (TTM)-0.65
EPS (Forward)-0.70
52W Range
18.8458% of range29.43
52W High29.43 USD
52W Low18.84 USD
Profitability
Gross Margin56.20%
Oper. Margin-47.42%
EBITDA Margin-36.81%
Profit Margin-40.18%
ROE18.76%
ROA-21.30%
Growth
Revenue Growth98.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-53.61M $
CapEx (TTM)6.38M $
FCF Margin—
FCF Yield—
Net Debt40.96M $
Net Debt/EBITDA-1.28
Balance Sheet
Debt/Equity-0.26
Current Ratio5.88
Quick Ratio3.50
Book Value/Sh-2.5690 USD
Cash/Share0.9320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)31.40 USD
Upside (mean)+25.9%
Target Range28.00 USD – 35.00 USD
$28.00+25.9% to mean$35.00
# Analysts5
Ownership
Shares Out.69.31M
Float36.08M
Insiders26.67%
Institutions33.06%
Short Interest
Short Ratio7.7d
Short % Float6.53%
Short % Out.4.03%
Shares Short2.79M
Short (prev mo.)1.77M
Technical
SMA 5022.98 (+8.6%)
SMA 20023.24 (+7.4%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)320.17K
Avg Vol (10d)299.52K
Technical Indicators
RSI (14)50.7
MACD1.0781
MACD Signal1.2047
MACD Hist.-0.1267
BB Upper29.67 USD
BB Middle25.44 USD
BB Lower21.21 USD
BB Width33.28%
ATR (14)1.840 USD
Vol Ratio (20d)1.11x